Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE

NCT ID: NCT04993638

Last Updated: 2024-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

147 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-01

Study Completion Date

2034-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

EUROSCUP MOBILE is intended for use in primary and revision total hip replacement surgery.

Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.

As part of post market vigilance, EUROS will collect data on EUROSCUP MOBILE performances and safety

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Post market observational study. This study is retropective and prospective, non comparative.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Arthropathy Hip Osteoarthritis Hip Arthritis Hip Fractures Hip Necrosis Hip Dysplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EUROSCUP MOBILE cementless

107 who received cementless version of EUROSCUP MOBILE

hip arthroplasty

Intervention Type DEVICE

Hip prosthesis surgery

EUROSCUP MOBILE cemented

40 who received cemented version of EUROSCUP MOBILE

hip arthroplasty

Intervention Type DEVICE

Hip prosthesis surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hip arthroplasty

Hip prosthesis surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient who received EUROSCUP MOBILE.
* Patient informed of its participation to the study
* Patient aged between 18 and 80 years old (\<80).

Exclusion Criteria

* Patient presenting a contraindication to EUROSCUP MOBILE implantation.
* Patient who refused to participate to the study
* Vulnerable subjects
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

EUROS

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Montagard

Avignon, , France

Site Status

CHU Gabriel Montpied

Clermont-Ferrand, , France

Site Status

Hôpital Saint Joseph-Saint Luc

Lyon, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EC-310-02-01-A

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hip Prospective Study
NCT05956236 RECRUITING